Copyright
©The Author(s) 2018.
World J Gastroenterol. Nov 14, 2018; 24(42): 4773-4786
Published online Nov 14, 2018. doi: 10.3748/wjg.v24.i42.4773
Published online Nov 14, 2018. doi: 10.3748/wjg.v24.i42.4773
Figure 5 Ubiquitin-like modifier activating enzyme 2 promotes gastric cancer migration and invasion in vitro.
A: Wound healing assay showed that knock-down of Uba2 inhibited migration of BGC-823 cells, while over-expression of Uba2 promoted migration of SGC-7901 cells (magnification: 50 ×). Data are shown as mean ± SD from three independent experiments; B: Transwell assays showed that knock-down of Uba2 inhibited migratory and invasion properties in BGC-823 cells, and over-expression of Uba2 in SGC-7901 cells showed the opposite effects (magnification: 100 ×). Data are shown as mean ± SD from three independent experiments; C: Alterations of MMP2, c-Myc, and MMP7 in BGC-823 and SGC-7901 cells. aP < 0.05, bP < 0.001 vs Control; and cP < 0.05, dP < 0.001 vs EV. EV: Empty vector; MMP: Matrix metalloproteinase; Uba2: Ubiquitin-like modifier activating enzyme 2.
- Citation: Li J, Sun X, He P, Liu WQ, Zou YB, Wang Q, Meng XW. Ubiquitin-like modifier activating enzyme 2 promotes cell migration and invasion through Wnt/β-catenin signaling in gastric cancer. World J Gastroenterol 2018; 24(42): 4773-4786
- URL: https://www.wjgnet.com/1007-9327/full/v24/i42/4773.htm
- DOI: https://dx.doi.org/10.3748/wjg.v24.i42.4773